Faculty of Pharma Sciences, Teikyo University		Lab page | Japanese
Laboratory of Hospital Pharmacy
	Publication List (Journals)
1.	Anticholinergic Load Is Associated with Swallowing Dysfunction in Convalescent Older Patients after a Stroke.; Kose E, Hirai T, Seki T, Okudaira M, Yasuno N; Nutrients., 14(10): 2121(2022)
2.	The Negative Association between Psychotropics and Hospital Stay in Older Patients with Osteoarthritis: A Retrospective Study.; Yamamoto T, Kose E, Okudaira M, Kawamura T, Yasui Y, Miyamoto W,NakagawaT, Kawano H, Yasuno N.; Journal of Geriatric Pharmacy., 5(3):16-23(2022)
3.	Association of pharmacist-led deprescribing intervention with the functional recovery in convalescent setting. ; Eiji Kose, Hidetatsu Endo, Hiroko Hori, Shingo Hosono, Chiaki Kawamura, Yuta Kodama, Takashi Yamazaki, Nobuhiro Yasuno. ; Pharmazie. 77: 165-170(2022)
4.	Pharmacist medication instructions are associated with continued medication self-management in older adults: a retrospective observational study.; Eiji Kose, Hidetatsu Endo, Hiroko Hori, Shingo Hosono, Chiaki Kawamura, Yuta Kodama, Takashi Yamazaki, Nobuhiro Yasuno.; J. Pharm. Health Care Sci. 7: 11(2021)
5.	The impact of decreasing potentially inappropriate medications on activities of daily living in a convalescent rehabilitation setting.; Eiji Kose, Toshiyuki Hirai, Toshiichi Seki, Nobuhiro Yasuno.; Int J Clin Pharm. 43: 577-585(2021)
6.	SLC23A3 is a renal hypoxanthine transporter; Makoto Hosoyamada, Naoko H. Tomioka, Tamaki Watanabe, Nobuhiro Yasuno, Shunya Uchida, Shigeru Shibata.; Nucleosides, Nucleotides & Nucleic Acids, Published online: 30 Jan (2022)
7.	Polypharmacy and Malnutrition Management of Elderly Perioperative Patients with Cancer: A Systematic Review; Kose E, Wakabayashi H, Yasuno N.; Nutrients, 13(6), 1961(2021)
8.	Awareness of Rapid-onset Opioid Formulations among Healthcare Professionals with Experience in Palliative Care: A Questionnaire Survey; Kose E, An T, Kikkawa A, Yasuno N.; I JCPP., 5(146), 1-6(2020)
9.	Drug-Induced Nutrient Deficiencies Among Older Adults; Kose E, Yasuno N.; J. Aging Sci., 8(3), 1-5(2020)
10.	Pharmacist medication instructions are associated with continued medication self-management in older adults: a retrospective observational study; Kose E, Endo H, Hori H, Hosono S, Kawamura C, Kodama Y, Yamazaki T, Yasuno N.; J Pharm Health Care Sci., 7(1), 1-8(2021)
11.	Emergency intensive care unit pharmacist’s intervention may reduce time to four-factor prothrombin complex concentrate administration: a retrospective study; Imanaka, S. Kuwabara, T., Ikeda, H., Miyake, Y., Enomoto, H., Sakamoto, T. and Yasuno, N.; J Pharm Health Care Sci., 6, 7 (2020)
12.	Anticholinergic Load and Nutritional Status in Older Individuals; Kose, E., Hirai, T., Seki, T., Yasuno, N.; J Nutr Health Aging., 24 (1), 20-27 (2020).
13.	Utility and effectiveness of Symbicort Turbuhaler (oral inhalation containing budesonide and formoterol) in a patient with severe asthma after permanent tracheostomy; Maeda, K., Yamaguchi, M., Nagase, H., Yasuno, N., Itagaki, F. and Watanabe, M.; Journal of Pharmaceutical Health Care and Sciences.,4:24 (2018)
14.	Treatment sequence in castration-resistant prostate cancer: A retrospective study in the new anti-androgen era.; Hoshi S, Numahata K, Ono K, Yasuno N, Bilim V, Hoshi K, Amemiya H, Sasagawa I, Ohta S.; Mol Clin Oncol. ;7(4):601-603(2017)
15.	Predictors of the therapeutic effect of sivelestat in patients with acute lung injury associated with systemic inflammatory response syndrome.; Takuma O., Kiyoshi M., Nobuhiro Y.; J Pharm Health Care Sci. 24;2(1):19(2016)
16.	Thrombin-Activatable Fibrinolysis Inhibitor in Chronic Thromboembolic Pulmonary Hypertension. ; Yaoita N, Satoh K Satoh T, Sugimura K, Tatebe S, Yamamoto S, Aoki T, Miura M, Miyata S, Kawamura T, Horiuchi H, Fukumoto Y, Shimokawa H,.Arterioscler Thromb Vasc Biol., Jun;36(6):1293-301(2016)
17.	The mechanism of false in vitro elevation of uric acid level in mouse blood.; Tamaki Watanabe, Naoko H. Tomioka, Shigekazu Watanabe, Yoshihiko Suzuki, Masao Tsuchiya, Makoto Hosoyamada，Biological & pharmaceutical bulletin，39(7), 1081-1084 (2016)
18.	Remarkable response to neoadjuvant therapy with methotrexate, vinblastine, adriamycin, and Cisplatin for undifferentiated bladder carcinoma: a case report and literature review.; Numahata K., Hoshi S., Hoshi K., Yasuno N., Kubo M., Sasagawa I., Ohta S.; Case Rep Oncol. 5;7(3):746-50(2014)
19.	Efficacy of once or twice weekly administration of epoetin κ in patients receiving hemodialysis: A retrospective study.; Ohta S., Yasuno N., Inomoto Y., Matsuda K., Nakagawa Y., Sasagawa I., Tanaka M.; Exp Ther Med.7(1):27-30(2014)
20.	False in vitro and in vivo elevations of uric acid levels in mouse blood.; Watanabe Tamaki, Tomioka Naoko, Watanabe Shigekazu, Tsuchiya Masao, Hosoyamada Makoto，Nucleosides, nucleotides & nucleic acids，33, 192-198 (2014)
21.	Macrophage migration inhibitory factor is a possible candidate for the induction of microalbuminuria in diabetic db/db mice.; Watanabe Tamaki, Tomioka Naoko, Doshi Masaru, Watanabe Shigekazu, Tsuchiya Masao, Hosoyamada Makoto，Biological & pharmaceutical bulletin，15(2), 741-747 (2013)
22.	Mutation analysis concerning possibility of cancer of unknown primary new treatment.; Ohta S., Cho Y., Onishi Y., Juni K., Oshima S., Hosoya O., Yasuno N., Iijima T., Saito H., Tanaka M., Kojima H.; J Cancer Ther Res Vol 2, 2 (2012)
23.	Proposal of a pharmacokinetically optimized dosage regimen of antibiotics in patients receiving continuous hemodiafiltration.; Yamamoto T, Yasuno N, Katada S, Hisaka A, Hanafusa N, Noiri E, Yahagi N, Fujita T, Suzuki H.; Antimicrob Agents Chemother.;55(12):5804-12(2011)
24.	The Application of Proteomics to PK-PD Modeling and Simulation. ; Sako K, Haniu H, Hasegawa M, Doi H, Yano S, Oosawa Y, Kishino T, Matsuki Y, Arisu Y, Kawamura T, Kimura M and Matsuda Y, J Bioequiv Availab.,(2011)
25.	Toll-like receptor 4-dependent adjuvant activity of Kakkon-to extract exists in the high molecular weight polysaccharide fraction.; Ishijima Y, Kawamura T, Kimura A, Kohno A, Okada T, Tsuji T, Watanabe Y. Int J Immunopathol Pharmacol., 24 (1):43-54(2011)
26.	Control of ER stress by a chemical　chaperone counteracts apoptotic signals in IFN-gamma-treated murine hepatocytes.; Kanki K, Kawamura T, Watanabe Y. Apoptosis., 14(3):309-19(2009)
27.	Solid Dispersion of Spironolactone with Porous Silica Particles by Solvent Method.; Tomomnobu U., Nobuhiro Y., Yoshitsugu Y. and Hiroshi S.; Pharmazie 62:599-603(2007)
28.	Hepatitis induced by an IgM monoclonal antibody against procarboxypeptidase R.; He L, Asai S, Kawamura T, Kimbara N , Tada T, Okada H, Okada N. Microbiol Immunol., 49(4): 373-80(2005)
29.	Chimeric human/murine monoclonal IgM antibodies to HIV-1 Nef antigen　expressed on chronically infected cells.; Kawai M, He L, Kawamura T, Omoto S, Fujii YR, Okada N. Microbiol Immunol., 47(3): 247-53(2003)
30.	Modulation of procarboxypeptidase R (ProCPR) activation by　complementary peptides to thrombomodulin.; Shimomura Y, Kawamura T, Komura H, Campbell W, Okada N, Okada H. Microbiol Immunol., 47(3): 241-5(2003;)
31.	Development of Ethenzamide Ointment as a Pain Relief for Postherpetic Neuralgia.; Yasuno N., Tsuchiya M., Kizu J., Watanabe M., Arakawa Y., Umeyama T., Kugimiya T.; Jpn.J.Hosp.Pharm. Health Care Sci. 28(4) 309-314(2002)
32.	Elastase from activated human neutrophils activates procarboxypeptidase R.; Kawamura T, Okada N, Okada H. Microbiol Immunol., 46(3): 225-30(2002)
33.	Preparation and Clinical Application of 2% Diflunisal Oral Ointment for painful Lesions of the Oral Mucosa.; Kizu J., Tsuchiya M., Watanabe S., Yasuno N., Arakawa Y., Saijyo H., Okuda O.; YAKUGAKU ZASSHI 121(11)829-835(2001)
34.	cDNA of a novel mRNA expressed predominantly in mouse kidney.; Kawamura T, Kuroda N, Kimura Y, Lazoura E, Okada N, Okada H. Biochem Genet., 39(1-2): 33-42 (2001)
.
	Publication List (Books)